SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate
将皂苷与全合成TLR4激动剂结合的SPA14脂质体可为hCMV候选疫苗提供佐剂作用
期刊:NPJ Vaccines
影响因子:6.9
doi:10.1038/s41541-024-01046-0
Ernesto Luna # ,Sophie Ruiz # ,Marie Garinot # ,Cyril Chavagnac ,Pankaj Agrawal ,John Escobar ,Laurent Revet ,Marie-Jeanne Asensio ,Fabienne Piras ,Francis G Fang ,Donald R Drake 3rd ,Bachra Rokbi ,Daniel Larocque ,Jean Haensler